Sign in
4

Changes in Ownership

Tango Therapeutics, Inc. Filed Acc 0000950170-24-012996

Chief Financial Officer sold 3,725 shares at an average $12.59 ($46,900)

From the SEC's structured data for this filing

Trades in this filing

Beckman Daniella · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-06 Sale : show line 1 in the form −1,908 $12.56 $23,969 134,214 D
2024-02-07 Sale : show line 2 in the form −1,817 $12.62 $22,930 132,397 D
Open-market sales · 3,725 sh · avg $12.59 · $46,900
Loading xslF345X05/ownership.xml…